Information  X 
Enter a valid email address

Puretech Health PLC Ord 1P (PRTC)

Related News

22-Nov-2019 08:10 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 460p (from 380p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
20-Nov-2019 08:30 AM

Broker Forecast - Liberum Capital issues a broker note on PureTech Health Plc

Liberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 450p (from 300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Aug-2019 08:10 AM

Broker Forecast - Liberum Capital issues a broker note on PureTech Health Plc

Liberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 347p (from 336p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Aug-2019 07:22 AM

PureTech Health losses widen on higher R&D spending, tax charge

Clinical stage biotechnology company PureTech Health booked a first-half loss after a gain in the value of its investments was offset by a higher tax charge and steeper R&D spending. Net losses for the six months through June amounted to $14.0m, compared
19-Jul-2019 08:10 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 380p (from 344p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Jul-2019 10:50 AM

Broker Forecast - Liberum Capital issues a broker note on PureTech Health Plc

Liberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 336p (from 308p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Apr-2019 09:31 AM

PureTech Health affiliate Gelesis receives $10.6m grant for first product

Biopharmaceutical company PureTech Health has announced that its affiliate Gelesis has received a $10.6m grant to support the commercial manufacturing of its first product, Plenity. The company said it hoped to launch Plenity in the United States in the
24-Apr-2019 09:31 AM

PureTech Health posts annual loss owing to treatment development spending

PureTech Health, which develops treatments for 'dysfunctions of the brain-immune-gut axis', booked an full-year loss as it ramped up R&D spending. Pre-tax losses for the year through December amounted to $68.4m, compared to losses of $70.7m on-
15-Apr-2019 08:00 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 344p (from 320p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Apr-2019 09:47 AM

PureTech's Sonde Health completes $16m financing for vocal biomarker screening tech

PureTech affiliate Sonde Health announced it had completed a $16m Series A financing round to advance Sonde's vocal biomarker technology. The proceeds from the financing would be used to progress the firm's capability across multiple health con
12-Mar-2019 09:10 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 320p (from 313p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Jan-2019 08:20 AM

Broker Forecast - Jefferies International issues a broker note on PureTech Health Plc

Jefferies International today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 255p (from 245p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Oct-2018 09:43 AM

PureTech's Vedanta Biosciences announce successful Phase1a/1b VE303 clinical study

The Vedanta Biosciences arm of biopharma company PureTech announced that preliminary results from its Phase 1a/1b clinical study of its live biotherapeutic product VE303 demonstrated safety, tolerability and proof of mechanism. The product, a treatment c
09-May-2018 12:00 PM

Broker Forecast - Jefferies International issues a broker note on PureTech Health Plc

Jefferies International today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and set its price target at 245p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
09-May-2018 10:40 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and set its price target at 313p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Apr-2018 08:09 AM

PureTech Health operating losses deepen on higher R&D spend

Biopharmaceutical group PureTech Health said annual operating losses deepened as revenue fell and it continued to study treatments for ADHD and obesity. The company is still in product development phase and the fall in revenue was caused by variances in
09-Apr-2018 07:14 AM

PureTech Health affiliate appoints new CEO

Commense, an affiliate of PureTech Health, announced the appointment of Edward J "Tad" Stewart as President and Chief Executive Officer. Mr Stewart will focus on advancing Commense's lead program towards the clinic, growing the company&apo
26-Jan-2018 10:40 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 313p (from 302p). Story provided by StockMarketWire.com...
19-Dec-2017 07:51 AM

PureTech Health announces affiliate's research collaboration with Eli Lilly

PureTech Health noted that Entrega, an affiliate of PureTech Health, announced a research collaboration with Eli Lilly. Under the initial agreement, Entrega will receive $5m in equity and research funding from Lilly to investigate the application of Entr
07-Dec-2017 09:30 AM

PureTech microbiome programme enters Phase 1 trial

PureTech Health affiliate Vedanta Biosciences has initiated a Phase 1a/1b clinical trial of VE303, the company's orally-administered, human microbiome-derived product candidate. VE303 is the first known investigational drug consisting of rationally
04-Dec-2017 01:20 PM

Broker Forecast - Numis issues a broker note on PureTech Health Plc

Numis today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 259p (from 233p). Story provided by StockMarketWire.com...
04-Dec-2017 08:30 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 302p (from 278p). Story provided by StockMarketWire.com...
30-Nov-2017 02:00 PM

Broker Forecast - Numis issues a broker note on PureTech Health Plc

Numis today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 233p (from 207p). Story provided by StockMarketWire.com...
30-Nov-2017 09:45 AM

PureTech's resTORbio raises $40m

PureTech Health's affiliate resTORbio has raised $40 million in an equity round. Together with a $25 million Series A financing that was completed earlier this year, the current financing brings the total 2017 investments in resTORbio to $65 millio
31-Oct-2017 10:20 AM

Broker Forecast - Peel Hunt issues a broker note on PureTech Health Plc

Peel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and set its price target at 278p. Story provided by StockMarketWire.com...
 
Headlines
Top categories

11-Dec-2019 09:00 AM

Broker Forecast - RBC Capital Markets issues a broker note on Beazley PLC

RBC Capital Markets today reaffirms its outperform investment rating on Beazley PLC (LON:BEZ) and cut its price target to 600p (from 650p). Story pro ...

Company finder

a d v e r t i s e m e n t